Abstract
Iron metabolism is pivotal for cell fitness in the mammalian host; however, its role in group 3 innate lymphoid cells (ILC3s) is unknown. Here we show that transferrin receptor CD71 (encoded by Tfrc)-mediated iron metabolism cell-intrinsically controls ILC3 proliferation and host protection against Citrobacter rodentium infection and metabolically affects mitochondrial respiration by switching of oxidative phosphorylation toward glycolysis. Iron deprivation or Tfrc ablation in ILC3s reduces the expression and/or activity of the aryl hydrocarbon receptor (Ahr), a key ILC3 regulator. Genetic ablation or activation of Ahr in ILC3s leads to CD71 upregulation or downregulation, respectively, suggesting Ahr-mediated suppression of CD71. Mechanistically, Ahr directly binds to the Tfrc promoter to inhibit transcription. Iron overload partially restores the defective ILC3 compartment in the small intestine of Ahr-deficient mice, consistent with the compensatory upregulation of CD71. These data collectively demonstrate an under-appreciated role of the Ahr-CD71–iron axis in the regulation of ILC3 maintenance and function.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout







Similar content being viewed by others
Data availability
All data supporting the findings of this study are available within the article and its supplementary materials. The M. musculus reference genome (GRCm38/mm10 assembly) https://www.ncbi.nlm.nih.gov/assembly/GCF_000001635.20/ was used for RNA-seq and ChIP-seq read alignment. The Gene Expression Omnibus accession code for the sequencing data in this paper is GSE222621. Source data are provided with this paper.
References
Lieu, P. T., Heiskala, M., Peterson, P. A. & Yang, Y. The roles of iron in health and disease. Mol. Asp. Med. 22, 1–87 (2001).
Hentze, M. W., Muckenthaler, M. U., Galy, B. & Camaschella, C. Two to tango: regulation of mammalian iron metabolism. Cell 142, 24–38 (2010).
Donovan, A. et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776–781 (2000).
Abboud, S. & Haile, D. J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275, 19906–19912 (2000).
McKie, A. T. et al. A novel duodenal iron-regulated transporter, ireg1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5, 299–309 (2000).
Dev, S. & Babitt, J. L. Overview of iron metabolism in health and disease. Hemodial. Int. 21, S6–S20 (2017).
Aydemir, T. B. & Cousins, R. J. The multiple faces of the metal transporter zip14 (slc39a14). J. Nutr. 148, 174–184 (2018).
Jenkitkasemwong, S. et al. Slc39a14 is required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis. Cell Metab. 22, 138–150 (2015).
Gammella, E., Buratti, P., Cairo, G. & Recalcati, S. The transferrin receptor: the cellular iron gate. Metallomics 9, 1367–1375 (2017).
Lill, R. Function and biogenesis of iron-sulphur proteins. Nature 460, 831–838 (2009).
Li, H. et al. Iron regulatory protein 2 modulates the switch from aerobic glycolysis to oxidative phosphorylation in mouse embryonic fibroblasts. Proc. Natl Acad. Sci. USA 116, 9871–9876 (2019).
Ye, H. et al. Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. J. Clin. Invest. 120, 1749–1761 (2010).
Cronin, S. J. F., Woolf, C. J., Weiss, G. & Penninger, J. M. The role of iron regulation in immunometabolism and immune-related disease. Front. Mol. Biosci. 6, 116 (2019).
Chen, A. C., Donovan, A., Ned-Sykes, R. & Andrews, N. C. Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasis. Proc. Natl Acad. Sci. USA 112, 11714–11719 (2015).
Barrientos, T. et al. Metabolic catastrophe in mice lacking transferrin receptor in muscle. eBioMedicine 2, 1705–1717 (2015).
Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517, 293–301 (2015).
Diefenbach, A., Colonna, M. & Koyasu, S. Development, differentiation, and diversity of innate lymphoid cells. Immunity 41, 354–365 (2014).
Abt, M. C. et al. Innate immune defenses mediated by two ilc subsets are critical for protection against acute Clostridium difficile infection. Cell Host Microbe 18, 27–37 (2015).
Song, C. et al. Unique and redundant functions of nkp46+ ilc3s in models of intestinal inflammation. J. Exp. Med. 212, 1869–1882 (2015).
Xiong, L. et al. Group 3 innate lymphoid cell pyroptosis represents a host defence mechanism against salmonella infection. Nat. Microbiol 7, 1087–1099 (2022).
McKenzie, A. N. J., Spits, H. & Eberl, G. Innate lymphoid cells in inflammation and immunity. Immunity 41, 366–374 (2014).
Silberger, D. J., Zindl, C. L. & Weaver, C. T. Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity. Mucosal Immunol. 10, 1108–1117 (2017).
Di Luccia, B., Gilfillan, S., Cella, M., Colonna, M. & Huang, S. C. Ilc3s integrate glycolysis and mitochondrial production of reactive oxygen species to fulfill activation demands. J. Exp. Med. 216, 2231–2241 (2019).
Fu, Z. et al. Mitochondrial transcription factor a in rorγt(+) lymphocytes regulate small intestine homeostasis and metabolism. Nat. Commun. 12, 4462 (2021).
Rothhammer, V. & Quintana, F. J. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat. Rev. Immunol. 19, 184–197 (2019).
Zhou, L. Ahr function in lymphocytes: emerging concepts. Trends Immunol. 37, 17–31 (2016).
Stockinger, B., Di Meglio, P., Gialitakis, M. & Duarte, J. H. The aryl hydrocarbon receptor: multitasking in the immune system. Annu. Rev. Immunol. 32, 403–432 (2014).
Qiu, J. et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92–104 (2012).
Lee, J. S. et al. Ahr drives the development of gut ilc22 cells and postnatal lymphoid tissues via pathways dependent on and independent of notch. Nat. Immunol. 13, 144–151 (2011).
Kiss, E. A. et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561–1565 (2011).
Quast, C. et al. The silva ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res. 41, D590–D596 (2013).
Robinette, M. L. et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat. Immunol. 16, 306–317 (2015).
Wang, Z. et al. Iron drives T helper cell pathogenicity by promoting rna-binding protein pcbp1-mediated proinflammatory cytokine production. Immunity 49, 80–92 (2018).
Wang, W. et al. Cd8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569, 270–274 (2019).
Muckenthaler, M. U., Galy, B. & Hentze, M. W. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (ire/irp) regulatory network. Annu. Rev. Nutr. 28, 197–213 (2008).
Allan, D. S. et al. An in vitro model of innate lymphoid cell function and differentiation. Mucosal Immunol. 8, 340–351 (2015).
Xu, W. et al. Lethal cardiomyopathy in mice lacking transferrin receptor in the heart. Cell Rep. 13, 533–545 (2015).
Xiong, L. et al. Ahr-foxp3-rorγt axis controls gut homing of cd4(+) T cells by regulating gpr15. Sci. Immunol. 5, eaaz7277 (2020).
Li, S. et al. Ikaros inhibits group 3 innate lymphoid cell development and function by suppressing the aryl hydrocarbon receptor pathway. Immunity 45, 185–197 (2016).
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
Bostick, J. W. et al. Dichotomous regulation of group 3 innate lymphoid cells by nongastric helicobacter species. Proc. Natl Acad. Sci. USA 116, 24760–24769 (2019).
Zelante, T. et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39, 372–385 (2013).
Cervantes-Barragan, L. et al. Lactobacillus reuteri induces gut intraepithelial cd4(+)cd8αα(+) t cells. Science 357, 806–810 (2017).
Ye, J. et al. The aryl hydrocarbon receptor preferentially marks and promotes gut regulatory T cells. Cell Rep. 21, 2277–2290 (2017).
Li, S. et al. Aryl hydrocarbon receptor signaling cell intrinsically inhibits intestinal group 2 innate lymphoid cell function. Immunity 49, 915–928 (2018).
Motamedi, M., Xu, L. & Elahi, S. Correlation of transferrin receptor (CD71) with ki67 expression on stimulated human and mouse T cells: the kinetics of expression of T cell activation markers. J. Immunol. Methods 437, 43–52 (2016).
Weinberg, E. D. Nutritional immunity. Host’s attempt to withold iron from microbial invaders. JAMA 231, 39–41 (1975).
Sakamoto, K. et al. IL-22 controls iron-dependent nutritional immunity against systemic bacterial infections. Sci. Immunol. 2, eaai8371 (2017).
Kortman, G. A. et al. Low dietary iron intake restrains the intestinal inflammatory response and pathology of enteric infection by food-borne bacterial pathogens. Eur. J. Immunol. 45, 2553–2567 (2015).
Müllner, E. W., Neupert, B. & Kühn, L. C. A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA. Cell 58, 373–382 (1989).
Koeller, D. M. et al. A cytosolic protein binds to structural elements within the iron regulatory region of the transferrin receptor mrna. Proc. Natl Acad. Sci. USA 86, 3574–3578 (1989).
Jabara, H. H. et al. A missense mutation in tfrc, encoding transferrin receptor 1, causes combined immunodeficiency. Nat. Genet. 48, 74–78 (2016).
Fernandez-Salguero, P. et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding ah receptor. Science 268, 722–726 (1995).
Eberl, G. et al. An essential function for the nuclear receptor rorgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64–73 (2004).
Aydemir, T. B. et al. Intestine-specific deletion of metal transporter zip14 (slc39a14) causes brain manganese overload and locomotor defects of manganism. Am. J. Physiol. Gastrointest. Liver Physiol. 318, G673–G681 (2020).
Guo, X. et al. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor stat3 mediates protection against intestinal infection. Immunity 40, 25–39 (2014).
Dobin, A. et al. Star: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Li, B. & Dewey, C. N. Rsem: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinform. 12, 323 (2011).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with deseq2. Genome Biol. 15, 550 (2014).
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with bowtie 2. Nat. Methods 9, 357–359 (2012).
Li, H. et al. The sequence alignment/map format and samtools. Bioinformatics 25, 2078–2079 (2009).
Quinlan, A. R. & Hall, I. M. Bedtools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
Meyer, L. R. et al. The UCSC genome browser database: extensions and updates 2013. Nucleic Acids Res. 41, D64–D69 (2013).
Patel, R. K. & Jain, M. NGS QC toolkit: a toolkit for quality control of next generation sequencing data. PLoS ONE 7, e30619 (2012).
Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576–589 (2010).
Lakhal-Littleton, S. et al. Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function. Proc. Natl Acad. Sci. USA 112, 3164–3169 (2015).
Kanamori, Y. et al. Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit+ il-7r+ thy1+ lympho-hemopoietic progenitors develop. J. Exp. Med. 184, 1449–1459 (1996).
Acknowledgements
We thank the Zhou laboratory for help and suggestions; R. Merkel and J. Kyu for mice genotyping; S. G. Swarts from the Department of Radiation Oncology of the University of Florida for assistance of HESKA; and Y. Sun from the Molecular Pathology Core, Department of Pathology of the University of Florida for tissue section and immunofluorescence staining support. Confocal microscopy was performed at the Center for Immunology & Transplantation. The Genomics Facility (University of Chicago) provided sequencing services and assistance. L.Z. is an Investigator in the Pathogenesis of Infectious Disease and is supported by the Burroughs Wellcome Fund. This work was supported by the National Institutes of Health grants AI132391 and AI157109 (to L.Z.).
Author information
Authors and Affiliations
Contributions
L.X. and L.Z. designed the study. L.X. performed experiments. E.Y.H. and N.S. assisted with part of the experiments. E.Y.H. and J.W.D. performed sequencing data analysis. F.R.J.R. provided reagents. L.Z. supervised the study. L.X. and L.Z. wrote the manuscript with the input from other authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Immunology thanks the anonymous reviewers for their contribution to the peer review of this work. Primary Handling Editor: S. Houston, in collaboration with the Nature Immunology team.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Iron-depleted diet impairs gut ILC3 maintenance and function (Related to Fig. 1).
3-week-old C57BL/6 wild-type (WT) mice were fed an iron-deficient (ID) or control (Ctrl) diet for 3 weeks before analysis. a and b, Hemoglobin concentrations (a) and MCV (b) in the indicated mice. Data are compiled from three independent experiments (n = 8 mice per group). c, Principal component analysis (PCA) plot of the RNA-seq for SI ILC3s in the indicated mice. d, Scatter-plot of log2 (FPKM) gene expression of FACS-sorted SI ILC3s from the indicated mice in RNA-seq analysis. DEGs (ID diet vs Ctrl diet, fold change ≥ 1.5, q value ≤ 0.05) are highlighted in blue (upregulated) and orange (downregulated), respectively (n = 3 mice per group). e, Heat map of the indicated gene expression in glycolysis pathway revealed by RNA-seq analysis. f, FACS analysis of Ahr expression in ILC3s of the mice with indicated treatments. Ahr–/– ILC3s were used as a negative control. Representative FACS plot of three independent experiments. g, Representative FACS gating/sorting strategies used for identification of different immune cell populations in this study.
Extended Data Fig. 2 Iron chelation represses ILC3 functions ex vivo and in vitro (Related to Fig. 2).
a–l, SI LPLs from WT mice were treated ex vivo with or without DFO for 16 h. Percentages of IFN-γ+ in ILC3s compiled from two independent experiments (n = 6 mice per group) (a), gMFI of MitoTracker Green FM (b), TMRE (c) and MitoSox (d) in ILC3s (n = 6 mice per group from two independent experiments). FACS analysis of CD71 expression in ILC2s and representative FACS plot of three independent experiments (e). Representative FACS plots (f), percentages of IL-5+ (g) and IL-13+ (h) cells in ILC2s compiled from two independent experiments (n = 6 mice per group) are shown. FACS analysis of CD71 expression in ILC1s and representative FACS plot of three independent experiments (i). Percentages of IFN-γ+ cells in ILC1s (j), IL-22+ (k) and IL-17A+ (l) cells in CD4+ T cells compiled from three independent experiments (n = 6 mice per group). m–s, LI LPLs from WT mice were treated ex vivo with or without DFO for 16 h. FACS analysis of CD71 (m) and RORγt (o) expression in ILC3s and representative FACS plots of three independent experiments are shown. gMFI of CD71 (n) and RORγt (p) expression in ILC3s from three independent experiments (n = 3 mice per group) are shown. FACS analysis of IL-22 and IL-17A expression in ILC3s and representative FACS plot of three independent experiments (q). Percentages of IL-22+ (r) and IL-17A+ (s) in ILC3s from three independent experiments (n = 3 mice per group). t and u, MNK-3 cells were treated with or without DFO for 16 h in vitro. gMFI of Ki-67 expression in MNK-3 cells (t) and percentages of MNK-3 cell viability (u) (n = 8 biologically independent replicates per group from three independent experiments).
Extended Data Fig. 3 Iron depletion impairs mitochondrial function and switches OXPHOS to glycolysis in ILC3s (Related to Fig. 3).
a, PCA of RNA-seq analysis of MNK-3 cells treated with or without DFO for 16 h in vitro (n = 3 biologically independent replicates per group). b–g, Mitochondrial mass and activity in MNK-3 cells. MitoTracker Green FM (b), TMRE (d) and MitoSox (f) intensity. Representative FACS plots of three independent experiments. gMFI of MitoTracker Green FM (c), TMRE (e) and MitoSox (g) (n = 6 biologically independent replicates per group). Data are compiled from three independent experiments. h–j, Mitochondrial mass and activity of ILC3s from WT mice fed an ID or Ctrl diet. gMFI of MitoTracker Green FM (h), TMRE (i) and MitoSox (j) in ILC3s (control diet: n = 7; ID diet: n = 5). Data are compiled from three independent experiments. k, FACS analysis of 2-NBDG uptake in MNK-3 cells. Representative FACS plot of three independent experiments. l–n, Seahorse metabolic flux analysis. Real-time ECAR (l) are representative of two independent experiments, and compiled data on quantification of basal (m) and maximal (n) ECAR of one experiment are shown (n = 3 biologically independent replicates per group). o and p, FACS analysis of IL-22 and IL-17A expression in MNK-3 cells transduced with the indicated retroviral constructs. The cells were treated with FICZ on day 2. Representative FACS plot (o) and percentages of IL-22+ cells in MNK-3 cells from two independent experiments (n = 6 biologically independent replicates per group) (p). q and r, FACS analysis of IL-22 and IL-17A expression in MNK-3 cells transduced with the indicated retroviral constructs. Representative FACS plot (q) and percentages of IL-22+ cells in MNK-3 cells compiled from two independent experiments (n = 3 biologically independent replicates per group) (r).
Extended Data Fig. 4 CD71 deficiency impairs ILC3 maintenance in a cell-intrinsic manner (Related to Fig. 4).
a, Tfrc mRNA determined by RT-qPCR in SI ILC3s. Data are compiled from three independent experiments (n = 3 mice per group). b and c, FACS analysis of intracellular Fe2+ in ILC3s. Representative FACS plot (b) and gMFI of Fe2+ in ILC3s (n = 3 mice per group) (c). d, Percentages of TH17 cells (CD4+TCRβ+Foxp3−GATA3−RORγt+) in CD4+ T cells from three independent experiments (Tfrcf/f: n = 6; Tfrcf/f Rorc-cre: n = 7). e–k, FACS analysis of ILC3 subsets. NKp46 and RORγt expression in Lin− (e), CD4 and RORγt expression in Lin−NKp46− (g), NKp46 and CCR6 expression in Lin−RORγt+ (j) LPLs. Percentages of NKp46+ ILC3s (f), CD4+ ILC3s (h) and CD4− ILC3s in Lin− (i), and CCR6+ in ILC3s (k) from three independent experiments (Tfrcf/f: n = 9; Tfrcf/f Rorc-cre: n = 7). l–n, FACS analysis of ILC3 cytokines. Representative FACS plot (l), percentages of IL-22+ (m) and IL-17A+ (n) cells in ILC3s from three independent experiments (Tfrcf/f: n = 9; Tfrcf/f Rorc-cre: n = 7). o and p, Percentages of Aqua+ in ILC3s from three independent experiments (Tfrcf/f: n = 7 per age; Tfrcf/f Rorc-cre: n = 6 (1-week-old and 4-week-old) or 5 (6-week-old)). q, FACS analysis of CD71 expression in CD4+ T cells and ILC3s. Representative FACS plots of three independent experiments. r and s, FACS analysis of RORγt expression in Lin− LPLs. Representative FACS plot (r) and percentages of ILC3s from three independent experiments (Rag1−/− Tfrcf/f: n = 7; Rag1−/− Tfrcf/f Rorc-cre: n = 6) (s). t and u, FACS analysis of RORγt expression in Lin− LPLs. Representative FACS plot (t) and percentages of ILC3s from three independent experiments (Tfrcf/f: n = 8; Tfrcf/f Cd4-cre: n = 6) (u).
Extended Data Fig. 5 CD71 ablation in ILC3s impairs gut immunity to C. rodentium infection (Related to Fig. 5).
Body weight (a) and survival (b) of C. rodentium-infected mice (Tfrcf/f: n = 8; Tfrcf/f Rorc-cre: n = 5). Statistical analysis by the log-rank test. Data are compiled from three independent experiments. c, TH17 percentages in CD4+ T cells in C. rodentium-infected mice from two independent experiments (for each time point: Tfrcf/f: n = 8 and 6; Tfrcf/f Rorc-cre: n = 4). d and e, FACS analysis of CD71 in ILC3s of WT (Tfrcf/f) mice treated with or without iron dextran. Representative FACS plot (d) and percentages of CD71+ cells in ILC3s from three independent experiments (n = 5 for untreated; n = 7 for treated) (e). f, Heat map of OXPHOS pathway and ILC3 signature genes by RNA-seq analysis of SI ILC3s (n = 3 mice per group). g, GSEA showing glycolysis gene pathway enrichment in the indicated ILC3s. h, Representative FACS plot of pS6 in ILC3s of three independent experiments. i–k, FACS analysis of mitochondrial mass and activity. gMFI of MitoTracker Green FM (i) (n = 3 mice per group), TMRE (j) (Tfrcf/f: n = 6; Tfrcf/f Rorc-cre: n = 4), MitoSox (k) (Tfrcf/f: n = 6; Tfrcf/f Rorc-cre: n = 5) in ILC3s from three independent experiments. l–q, RNA-seq analysis of SI ILC3s from mice with or without iron dextran treatment (n = 3 mice per group). Heat map of the DEGs by RNA-seq analysis in the indicated ILC3s shown in Fig. 5h (l). GSEA showing ILC3 signature gene enrichment (m). FPKM of Ahrr, Gem and Osgin1 in the indicated ILC3s (n–p) (n = 3 mice per group). GO analysis showing enriched top 10 pathways of the shared 235 DEGs (cKO vs WT, with or without iron dextran) shown in Fig. 5h (q).
Extended Data Fig. 6 Zip14 is a NTBI transporter in ILC3s (Related to Fig. 5).
a, FACS analysis of RORγt expression in Lin− LPLs of the indicated mice, with or without iron dextran treatment. Representative FACS plot of three independent experiments are shown. b, Schematic depiction of experimental design for iron dextran pre-treatment, followed by C. rodentium infection. c, FPKM of literature-reported iron-related potential transporters in RNA-seq of SI ILC3s from WT mice (n = 3 mice per group). d, FPKM of RNA-seq of MNK-3 cells treated with or without DFO (100 µM) for 16 h in vitro (n = 3 biologically independent replicates per group). e, Expression of Slc39a14 and Slc39a8 mRNA determined by RT-qPCR in ILC3s from SI LPLs of Zipf/f and Zip14f/f Rorc-cre littermate mice. Data are representative of two independent experiments (n = 3 mice per group). f, FACS analysis of RORγt expression in Lin− LPLs of the indicated mice. Representative FACS plot of three independent experiments. g, FACS analysis of RORγt expression in Lin− LPLs of the indicated mice with or without iron dextran treatment. Representative FACS plot of three independent experiments. h and i, Expression of Slc39a8 and Slc11a2 mRNA determined by RT-qPCR in ILC3s from the indicated mice treated with iron dextran (n = 3 mice per group). Data are compiled from two independent experiments.
Extended Data Fig. 7 Microbiota inhibit CD71 expression in an Ahr-dependent manner (Related to Fig. 6).
a–d, Fecal microbiome analysis of the indicated mice. Bacterial (Class) abundance (a) and Shannon Index measuring bacterial diversity (b) revealed by 16 S rRNA gene sequencing in the indicated cohoused mice (Tfrcf/f: n = 7; Tfrcf/f Rorc-cre: n = 6). Data are displayed as box and whisker plots showing the median and the 25th and 75th percentiles and two whiskers at the minimum and maximum Shannon Entropy Index. Statistical significance was determined using the Kruskal-Wallis test. H. apodemus (c) and H. typhlonius (d) bacterial abundance measured by qPCR in the indicated cohoused mice (Tfrcf/f: n = 7; Tfrcf/f Rorc-cre: n = 6). e–g, FACS analysis of CD71 expression in ILC3s and TH17 cells in WT SPF and GF mice. Representative FACS plot (e) and percentages of CD71+ cells in ILC3s from three independent experiments (n = 7 mice per group) are shown (f). Percentages of CD71+ cells in TH17 cells from three independent experiments (n = 7 mice per group) are shown (g). Representative FACS plot of CD71 (h) and percentages of CD71+ cells in ILC3s from LI LPLs of the indicated mice treated with broad-spectrum antibiotics (abx) or control water. Data are compiled from five independent experiments (n = 10 for controls; n = 8 for abx-treated) (i). Representative FACS plot (j) and percentages of IL-22+ cells in ILC3s from four independent experiments (Ahr+/+: n = 8 and 7 for control and abx-treated groups; Ahr−/−: n = 7 and 5 for control and abx-treated groups) (k). l–n, Il22 (l), Ahrr (m) and Cyp1a1 (n) mRNA determined by RT-qPCR in LI tissues of the indicated mice treated with abx or control water (n = 3 mice per group compiled from two independent experiments).
Extended Data Fig. 8 Ahr cell-intrinsically inhibits CD71 transcription in ILC3s (Related to Fig. 6).
a–f, CD71+ percentages in the indicated cells. Data are compiled from three independent experiments (a–d: Ahr+/+: n = 4 and 8 for SI and LI; Ahr−/−: n = 4 and 6 for SI and LI); (e and f: n = 4 mice per group). g–k, FACS analysis of CD71 in the indicated cells. Representative FACS plots (g and i), and CD71+ percentages in ILC1s (h), ILC2s (j), TH17 cells (k) from three independent experiments (Ahr+/+: n = 6; AhrdCAIR/+: n = 7; AhrdCAIR/dCAIR: n = 8). l–q, FACS analysis of CD71 in the indicated ILC3s with or without IL-23 and IL-1β treatment for 6 hours ex vivo. Representative FACS plot (l) and CD71+ percentages in ILC3s compiled from three independent experiments (Ahr+/+: n = 10 per group; Ahr−/−: n = 8 per group) (m). Tfrc mRNA (n), gMFI of the Ahr (o), Ahr (p) and Ahrr (q) mRNAs determined by RT-qPCR in the indicated SI ILC3s (n = 6 mice per group from three independent experiments). r–t, Mixed bone marrow (BM) experiment. Data are compiled from two independent experiments (n = 3 mice per group). A schematic depiction of experimental design (note: donor cells were age and sex matched; recipients and donors were sex matched) (r), and CD71+ percentages in the indicated ILC3s (s) and ILC2s (t). u and v, FACS analysis of CD71 in ILC3s. Representative FACS plot (u) and CD71+ percentages in ILC3s from two independent experiments (n = 3 mice per group) (v). w and x, FACS analysis of IL-17A and IL-22 in ILC3s. Absolute numbers of IL-17A+ (w) and IL-22+ (x) ILC3s in the indicated mice (n = 5 mice per group from two independent experiments).
Extended Data Fig. 9 Iron treatment alleviates ILC3 defects in Ahr-deficient mice (Related to Fig. 6).
a and b, LI-ILC3 percentages in Lin− LPLs (a) and absolute numbers (b) in the indicated mice with or without iron dextran treatment. Data are compiled from three independent experiments (Ahr+/+: n = 7 and 8 for untreated and treated; Ahr−/−: n = 5 and 6 for untreated and treated). c–e, FACS analysis of IL-22 and IL-17A expression in SI ILC3s of the indicated mice. Representative FACS plot (c), IL-22+ (d) and IL-17A+ (e) percentages in the indicated ILC3s from three independent experiments (Ahr+/+: n = 7 and 8 for untreated and treated; Ahr−/−: n = 5 and 6 for untreated and treated). f and g, FACS analysis of RORγt in Lin− LPLs of the mice with indicated treatment. Representative FACS plot (f) and LI-ILC3 percentages in Lin− LPLs from three independent experiments (g) (Ahrf/f: n = 6 and 5 for untreated and treated; Ahrf/f Rorc-cre: n = 6 mice per group). h and i, Numbers of CCR6+ ILC3s (h) and NKp46+ ILC3s (i) in SI LPLs of the indicated mice from three independent experiments (Ahrf/f: n = 6 and 5 for untreated and treated; Ahrf/f Rorc-cre: n = 6 mice per group). j, Cryptopatches (CPs)/intestinal lymphoid follicles (ILFs) in representative SI sections of the indicated mice were stained with RORγt (red), CD3 (green), and DAPI (blue) and analyzed by fluorescence microscopy. Scale bar, 100 µm. Data are representative of two independent experiments. k, Numbers of CPs/ILFs in the SI of the indicated mice (n = 3 mice per group compiled from two independent experiments). l, Percentages of Aqua+ in SI ILC3s from three independent experiments (Ahrf/f: n = 6 and 5 for untreated and treated; Ahrf/f Rorc-cre: n = 6 mice per group).
Extended Data Fig. 10 Ahr regulates CD71 transcription by directly binding to the Tfrc locus (Related to Fig. 7).
a–e, RNA-seq analysis of ILC3s from SI and LI LPLs of Rag1−/−Ahr+/+ (WT) and Rag1−/−Ahr−/− (KO) littermate mice (n = 2 mice per group). PCA plot revealed by RNA-seq analysis of ILC3s from the indicated mice (a). Heat maps of the indicated mitochondria-encoding gene expression revealed by RNA-seq analysis (b). GSEA showing enrichment of ILC3 signature genes in SI (c) and LI (d) ILC3s in RNA-seq analysis. Heat maps of the ILC3 signature gene expression revealed by RNA-seq analysis (e). f, Schematic depiction of the Ahr motifs (highlighted in red) in the Ahr ChIP-seq peak at the Tfrc promoter. g, The firefly luciferase pTfrc-pGL2B or pTfrcΔXRE-pGL2B constructs and pRL-TK-Renilla luciferase construct were co-transfected into HEK293T cells, together with Ahr-expression or control plasmids. Cells were stimulated with or without FICZ and the firefly luciferase activity was normalized to Renilla luciferase activity. Representative data of two independent experiments (n = 3 biologically independent replicates per group from one experiment) are shown.
Supplementary information
Supplementary Information
Supplementary Table 1
Source data
Source Data Fig. 1
Statistical Source Data.
Source Data Fig. 2
Statistical Source Data.
Source Data Fig. 3
Statistical Source Data.
Source Data Fig. 4
Statistical Source Data.
Source Data Fig. 5
Statistical Source Data.
Source Data Fig. 6
Statistical Source Data.
Source Data Fig. 7
Statistical Source Data.
Source Data Extended Data Fig. 1
Statistical Source Data.
Source Data Extended Data Fig. 2
Statistical Source Data.
Source Data Extended Data Fig. 3
Statistical Source Data.
Source Data Extended Data Fig. 4
Statistical Source Data.
Source Data Extended Data Fig. 5
Statistical Source Data.
Source Data Extended Data Fig. 6
Statistical Source Data.
Source Data Extended Data Fig. 7
Statistical Source Data.
Source Data Extended Data Fig. 8
Statistical Source Data.
Source Data Extended Data Fig. 9
Statistical Source Data.
Source Data Extended Data Fig. 10
Statistical Source Data.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xiong, L., Helm, E.Y., Dean, J.W. et al. Nutrition impact on ILC3 maintenance and function centers on a cell-intrinsic CD71–iron axis. Nat Immunol 24, 1671–1684 (2023). https://doi.org/10.1038/s41590-023-01612-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-023-01612-z